Skip to main content
. 2023 Aug 23;14:1236465. doi: 10.3389/fendo.2023.1236465

Figure 1.

Figure 1

Patient disposition. *Patient was randomly allocated to osilodrostat but did not receive any study treatment because of a serious AE (grade 4 pituitary apoplexy that required hospitalization prior to receiving any study drug) that was not considered related to treatment.